Atria Investments LLC Sage Therapeutics, Inc. Transaction History

Atria Investments LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	BUY	$26.15 - $77.24 $123,924 - $366,040	4,739 Added 165.99%	7,594 $218,000
Q4 2019 Feb 11, 2020	BUY	$60.18 - $154.77 $45,676 - $117,470	759 Added 36.21%	2,855 $206,000
Q3 2019 Nov 14, 2019	BUY	$140.29 - $189.96 $9,960 - $13,487	71 Added 3.51%	2,096 $294,000
Q2 2019 Aug 26, 2019	BUY	$157.85 - $183.09 $319,646 - $370,757	2,025 New	2,025 $331,000
Q2 2019 Aug 09, 2019	SELL	$157.85 - $183.09 $321,856 - $373,320	-2,039 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$89.33 - $163.65 $15,454 - $28,311	-173 Reduced 7.82%	2,039 $324,000
Q4 2018 Feb 12, 2019	BUY	$81.94 - $139.71 $55,473 - $94,583	677 Added 44.1%	2,212 $212,000
Q3 2018 Oct 09, 2018	BUY	$138.11 - $169.04 $19,473 - $23,834	141 Added 10.11%	1,535 $217,000
Q2 2018 Jul 13, 2018	BUY	$140.36 - $175.76 $195,661 - $245,009	1,394 New	1,394 $218,000

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $340M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

Stay updated on Atria Investments LLC with notifications on news.